A bill that would establish programs in Florida to “import prescription drugs from Canada and other foreign nations” is slowly making its way through the Florida legislature. The Florida House Subcommittee on Health Quality approved HB19 this morning. But it will be a long time before Floridians can expect to see any impact from the bill.
Governor Ron DeSantis called for lawmakers to pave the way for foreign prescription drugs as a way to lower health care costs, but experts say the downside is a significant reduction in quality and safety. Under current law, the U.S. Food and Drug Administration exerts strict oversight on prescription medication and consumer protection from unsafe prescription drugs imported from other countries.
But a pharmacists group testified before the committee on Tuesday morning that there is a safer alternative to dangerous foreign imports: cutting out an unneeded middleman that artificially jacks up prescription drug prices. While HB19 would add a number of “quasi-regulations” designed to give the appearance of safety to consumers, Florida’s legislature can’t regulate Canadian drug companies. That’s why many pharmacists who do business in Florida are urging lawmakers to take a different approach – one they say is safer and more effective.
Dawn Butterfield, the owner of West Cocoa Pharmacy in Cocoa, Florida, traveled to Tallahassee to tell lawmakers about what she and like-minded pharmacists see as two signficant problems with the bill: patient safety, and the fact that the bill does nothing to address the problems created by pharmacy benefit managers (PBM’s) which act as little more than middlemen to drive up costs for consumers and pharmacists alike.
“This bill is a non-starter with pharmacists,” said Butterfield. “It’s a distraction from the real problem that is causing the spike in drug prices. We’re wasting our time fighting bad and potentially unsafe legislation instead of eliminating the middleman that is costing everyone money.”
Butterfield explained that drug companies often offer rebates on specific types of drugs, but more often than not, when a pharmacy benefit manager is involved, those rebates don’t get passed to the consumer or the pharmacist.
But the bigger problem, Butterfield says, are the dangers of importing drugs from outside the United States.
Canada, for example, offered a strain of oxycontin that was significantly more addictive than the brands offered in the United States. The Canadian government was slow to react to the problem, which made an already bad opioid epidemic even worse on the Canadian side of the border.
And pharmacy advocates warn that it will be even easier for counterfeit drugs to make their way into the United States with legislation that makes it legal to import drugs from overseas.
I agree with Dawn Butterfield and Pharmacists United for Truth and Transparency. PBM’s have been operating in the shadows for too long now and they are the main reason drugs are so expensive. We need laws that force PBM’s to operate in a transparent way. Rick Upson RPh Owner of Palm Beach Compounding Pharmacy
Agreed. Even though PBMs state that they help control drug pricing, they have done nothing of the sort. Drug pricing has skyrocketed exponentially over the past few years while PBMs have made billions in profits. In science, we call that cause and effect. Don’t let them (PBMs) fool you! They need to evaporate!
PBM’s are the spawn of Satan! They have done NOTHING to lower the cost of prescriptions. (How could something which takes BILLIONS of dollars OUT of the process actually LOWER the end cost? It can’t!) My pharmacy now fills more than 100 prescriptions per week BELOW our final net cost because the PBM’s force us to – but patients don’t get the benefit of the lower cost because the PBM’s take it for themselves. We used to have a nice, sustainable business which contributed to our community. Now we are fighting the PBM’s to stay alive! PBM’s HAVE to be stopped!
No scheduled drugs such OxyContin is allowed to be sent from Canada to the US.
That statement is untrue and misleading.